Synaptogenix Inc (SNPX)
4.70
-0.04
(-0.84%)
USD |
NASDAQ |
May 01, 16:00
4.70
0.00 (0.00%)
After-Hours: 17:46
Synaptogenix Price to Book Value: 0.2095 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 0.2113 |
April 29, 2024 | 0.1985 |
April 26, 2024 | 0.2019 |
April 25, 2024 | 0.1967 |
April 24, 2024 | 0.2033 |
April 23, 2024 | 0.2037 |
April 22, 2024 | 0.1944 |
April 19, 2024 | 0.193 |
April 18, 2024 | 0.2077 |
April 17, 2024 | 0.214 |
April 16, 2024 | 0.2073 |
April 15, 2024 | 0.197 |
April 12, 2024 | 0.2089 |
April 11, 2024 | 0.2151 |
April 10, 2024 | 0.2095 |
April 09, 2024 | 0.2202 |
April 08, 2024 | 0.2403 |
April 05, 2024 | 0.2229 |
April 04, 2024 | 0.2017 |
April 03, 2024 | 0.2006 |
April 02, 2024 | 0.2049 |
April 01, 2024 | 0.2047 |
March 28, 2024 | 0.2089 |
March 27, 2024 | 0.2123 |
March 26, 2024 | 0.2207 |
Date | Value |
---|---|
March 25, 2024 | 0.2037 |
March 22, 2024 | 0.2085 |
March 21, 2024 | 0.2162 |
March 20, 2024 | 0.2191 |
March 19, 2024 | 0.2351 |
March 18, 2024 | 0.2195 |
March 15, 2024 | 0.2251 |
March 14, 2024 | 0.2006 |
March 13, 2024 | 0.1995 |
March 12, 2024 | 0.195 |
March 11, 2024 | 0.1984 |
March 08, 2024 | 0.1821 |
March 07, 2024 | 0.1816 |
March 06, 2024 | 0.1837 |
March 05, 2024 | 0.1903 |
March 04, 2024 | 0.1862 |
March 01, 2024 | 0.2023 |
February 29, 2024 | 0.2152 |
February 28, 2024 | 0.2146 |
February 27, 2024 | 0.1989 |
February 26, 2024 | 0.1869 |
February 23, 2024 | 0.183 |
February 22, 2024 | 0.1853 |
February 21, 2024 | 0.2627 |
February 20, 2024 | 0.2009 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1131
Minimum
Sep 20 2023
8.792
Maximum
Feb 10 2021
1.277
Average
1.289
Median
Price to Book Value Benchmarks
CEL-SCI Corp | 6.059 |
AIM ImmunoTech Inc | 2.039 |
IGC Pharma Inc | 3.520 |
NovaBay Pharmaceuticals Inc | 1.968 |
Protalix BioTherapeutics Inc | 2.633 |
Price to Book Value Related Metrics
Price | 4.70 |
Earnings Yield | -920.8% |
Market Cap | 5.101M |